About DCS Innovative Diagnostik Systeme
DCS Innovative Diagnostik Systeme is a Healthcare company based in Hamburg (Germany) founded in 1992, and was acquired by Calibre Scientific in June 2024. Diagnostic reagents, antibodies, and detection systems for histopathology are manufactured. Its chief executive, as recorded, is Christian Sartori. DCS Innovative Diagnostik Systeme offers products and services including GenomeMe Antibodies, BioGenex Antibodies, Immunfärbesystem i6000 TM, Claudin 18.2 Antibodies, and Primär-Antikörper. Its focus areas include Diversified Diagnostics, Tests, Life Sciences and Genomics. Its legal entity is DCS Innovative Diagnostic Systems Dr. Christian Sartori GmbH & Co. KG.
Company details
Founded in 1992 in Hamburg, Germany, immunological and biochemical reagents are produced by DCS Innovative Diagnostik Systeme for diagnostic applications. Primary and secondary antibodies, chromogenic reagents, and automation systems for histopathology workflows are included in the offerings. The Sartori Test, a chemosensitivity assay, is provided to evaluate tumor responses to drugs and guide patient treatment selection. Operations focus on the medical diagnostics sector.
- Headquarters Hamburg, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dcs-diagnostics.de/home
- Social LinkedIn
- Acquired by Calibre Scientific (Jun 2024)
- Legal Name Dcs Innovative Diagnostic Systems Dr. Christian Sartori Gmbh & Co. Kg
- Investors
- Acquired byCalibre Scientific
(Jun 2024)
Products & Services of DCS Innovative Diagnostik Systeme
DCS Innovative Diagnostik Systeme offers a comprehensive portfolio of products and services, including GenomeMe Antibodies, BioGenex Antibodies, Immunfärbesystem i6000 TM, Claudin 18.2 Antibodies, and Primär-Antikörper.
Antibodies for exclusive diagnostic applications in healthcare.
Established antibodies for immuno detection purposes.
Automation tool for immuno staining processes.
Specialized antibodies for medical diagnostic use.
Primary antibodies from DB Biotech for diagnostics.
Investors in DCS Innovative Diagnostik Systeme
DCS Innovative Diagnostik Systeme has secured backing from 1 investor. Prominent investors backing the company include Calibre Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of contract based research, manufacturing, distribution and other services for biopharma sector | 2016 | calibrescientific.com | Los Angeles, United States |
Investor details for DCS Innovative Diagnostik Systeme
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DCS Innovative Diagnostik Systeme
1 people are tracked at DCS Innovative Diagnostik Systeme (1 in leadership).
| Name | Role | Group |
|---|---|---|
Christian Sartori | CEO | Leadership |
Complete people profiles for DCS Innovative Diagnostik Systeme
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DCS Innovative Diagnostik Systeme
2 dated milestones of DCS Innovative Diagnostik Systeme across 32 years, from founding to its latest funding, stage changes and deals.
- Founded DCS Innovative Diagnostik Systeme is founded.
- Exit Acquired by Calibre Scientific.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dcs Innovative Diagnostik Systeme
Complete news archive for DCS Innovative Diagnostik Systeme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DCS Innovative Diagnostik Systeme
DCS Innovative Diagnostik Systeme was founded in 1992.
DCS Innovative Diagnostik Systeme is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Christian Sartori is the CEO of DCS Innovative Diagnostik Systeme, as recorded in our data.
Founded in 1992 in Hamburg, Germany, immunological and biochemical reagents are produced by DCS Innovative Diagnostik Systeme for diagnostic applications. Primary and secondary antibodies, chromogenic reagents, and automation systems for histopathology workflows are included in the offerings. The Sartori Test, a chemosensitivity assay, is provided to evaluate tumor responses to drugs and guide patient treatment selection. Operations focus on the medical diagnostics sector.
DCS Innovative Diagnostik Systeme offers GenomeMe Antibodies, BioGenex Antibodies, Immunfärbesystem i6000 TM, Claudin 18.2 Antibodies, and Primär-Antikörper.
DCS Innovative Diagnostik Systeme has 1 investor. Key investors include Calibre Scientific.
DCS Innovative Diagnostik Systeme operates through Dcs Innovative Diagnostic Systems Dr. Christian Sartori Gmbh & Co. Kg.
Yes. DCS Innovative Diagnostik Systeme was acquired by Calibre Scientific in June 2024.